Literature DB >> 15932500

Mammalian Toll-like receptors: to immunity and beyond.

P A Hopkins1, S Sriskandan.   

Abstract

Toll-like receptors (TLRs) constitute an archetypal pattern recognition system. Their sophisticated biology underpins the ability of innate immunity to discriminate between highly diverse microbial pathogens and self. However, the remarkable progress made in describing this biology has also revealed new immunological systems and processes previously hidden to investigators. In particular, TLRs appear to have a fundamental role in the generation of clonal adaptive immune responses, non-infectious disease pathogenesis and even in the maintenance of normal mammalian homeostasis. Although an understanding of TLRs has answered some fundamental questions at the host-pathogen interface, further issues, particularly regarding therapeutic modulation of these receptors, have yet to be resolved.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15932500      PMCID: PMC1809390          DOI: 10.1111/j.1365-2249.2005.02801.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  176 in total

1.  The extracellular toll-like receptor 2 domain directly binds peptidoglycan derived from Staphylococcus aureus.

Authors:  Daisuke Iwaki; Hiroaki Mitsuzawa; Seiji Murakami; Hitomi Sano; Masanori Konishi; Toyoaki Akino; Yoshio Kuroki
Journal:  J Biol Chem       Date:  2002-05-01       Impact factor: 5.157

2.  Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4.

Authors:  Geoffrey B Johnson; Gregory J Brunn; Yuzo Kodaira; Jeffrey L Platt
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

3.  IRAK-M is a negative regulator of Toll-like receptor signaling.

Authors:  Koichi Kobayashi; Lorraine D Hernandez; Jorge E Galán; Charles A Janeway; Ruslan Medzhitov; Richard A Flavell
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

4.  Gamma interferon and granulocyte/monocyte colony-stimulating factor prevent endotoxin tolerance in human monocytes by promoting interleukin-1 receptor-associated kinase expression and its association to MyD88 and not by modulating TLR4 expression.

Authors:  Minou Adib-Conquy; Jean-Marc Cavaillon
Journal:  J Biol Chem       Date:  2002-05-24       Impact factor: 5.157

5.  Regulation of Toll-like receptor 4 expression in the lung following hemorrhagic shock and lipopolysaccharide.

Authors:  Jie Fan; Andras Kapus; Philip A Marsden; Yue Hua Li; George Oreopoulos; John C Marshall; Stefan Frantz; Ralph A Kelly; Ruslan Medzhitov; Ori D Rotstein
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

6.  Gram-negative flagellin-induced self-tolerance is associated with a block in interleukin-1 receptor-associated kinase release from toll-like receptor 5.

Authors:  Steven B Mizel; James A Snipes
Journal:  J Biol Chem       Date:  2002-04-12       Impact factor: 5.157

7.  Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.

Authors:  Elizabeth A Leadbetter; Ian R Rifkin; Andreas M Hohlbaum; Britte C Beaudette; Mark J Shlomchik; Ann Marshak-Rothstein
Journal:  Nature       Date:  2002-04-11       Impact factor: 49.962

8.  Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.

Authors:  Veit Hornung; Simon Rothenfusser; Stefanie Britsch; Anne Krug; Bernd Jahrsdörfer; Thomas Giese; Stefan Endres; Gunther Hartmann
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

9.  Toll-like receptor 4 polymorphisms and atherogenesis.

Authors:  Stefan Kiechl; Eva Lorenz; Markus Reindl; Christian J Wiedermann; Friedrich Oberhollenzer; Enzo Bonora; Johann Willeit; David A Schwartz
Journal:  N Engl J Med       Date:  2002-07-18       Impact factor: 91.245

10.  Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation.

Authors:  Martha Triantafilou; Kensuke Miyake; Douglas T Golenbock; Kathy Triantafilou
Journal:  J Cell Sci       Date:  2002-06-15       Impact factor: 5.285

View more
  64 in total

1.  Toll-like receptor (TLR) 4 polymorphism Asp299Gly is not associated with disease course in Dutch sarcoidosis patients.

Authors:  M Veltkamp; J C Grutters; C H M van Moorsel; H J T Ruven; J M M van den Bosch
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

Review 2.  Vaccines: all things considered.

Authors:  Ken S Rosenthal; Daniel H Zimmerman
Journal:  Clin Vaccine Immunol       Date:  2006-08

3.  Expression and functional analysis of toll-like receptors of peripheral blood cells in asthmatic patients: implication for immunopathological mechanism in asthma.

Authors:  Samantha W M Lun; C K Wong; Fanny W S Ko; David S C Hui; Christopher W K Lam
Journal:  J Clin Immunol       Date:  2008-12-06       Impact factor: 8.317

4.  Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis.

Authors:  M Veltkamp; P A H M Wijnen; C H M van Moorsel; G T Rijkers; H J T Ruven; M Heron; O Bekers; A M E Claessen; M Drent; J M M van den Bosch; J C Grutters
Journal:  Clin Exp Immunol       Date:  2007-06-12       Impact factor: 4.330

5.  Induction of toll-like receptor 2 positive antigen-presenting cells in spleen of pristane-induced arthritis in rats.

Authors:  Wenhua Zhu; Liesu Meng; Congshan Jiang; Weikun Hou; Jing Xu; Bo Wang; Shemin Lu
Journal:  Mol Biol Rep       Date:  2011-07-03       Impact factor: 2.316

6.  Immunomics of the koala (Phascolarctos cinereus).

Authors:  Kendra C Abts; Jamie A Ivy; J Andrew DeWoody
Journal:  Immunogenetics       Date:  2015-03-13       Impact factor: 2.846

7.  miR-140-5p Attenuates Neuroinflammation and Brain Injury in Rats Following Intracerebral Hemorrhage by Targeting TLR4.

Authors:  Shunda Wang; Yujie Cui; Jiaqi Xu; Heng Gao
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

8.  Dual TLR2 and TLR7 agonists as HIV latency-reversing agents.

Authors:  Amanda B Macedo; Camille L Novis; Caroline M De Assis; Eric S Sorensen; Paula Moszczynski; Szu-Han Huang; Yanqin Ren; Adam M Spivak; R Brad Jones; Vicente Planelles; Alberto Bosque
Journal:  JCI Insight       Date:  2018-10-04

9.  Local interleukin-1-driven joint pathology is dependent on toll-like receptor 4 activation.

Authors:  Shahla Abdollahi-Roodsaz; Leo A B Joosten; Marije I Koenders; Ben T van den Brand; Fons A J van de Loo; Wim B van den Berg
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

10.  Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunity.

Authors:  Simon S Jensen; Monika Gad
Journal:  J Inflamm (Lond)       Date:  2010-07-27       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.